Related Experiment Video
Updated: Sep 18, 2025

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
Published on: October 21, 2022
Rational Design and Immunological Mechanisms of Circular RNA-Based Vaccines: Emerging Frontiers in Combating Pathogen
Ying Zhang1,2,3, Shumei Jin4, Zan Zuo1,2,3
1Yunnan Provincial Key Laboratory of Clinical Virology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming 650032, China.
Circular RNA (circRNA) vaccines offer a promising new approach to combat infectious diseases, showing high stability and sustained antigen expression. This novel platform holds potential against various pathogens, including antibiotic-resistant bacteria, as an alternative to traditional vaccines.
Area of Science:
- Vaccinology
- Molecular Biology
- Immunology
Background:
- Traditional vaccines face limitations in immunogenicity, safety, and manufacturing.
- Circular RNA (circRNA) vaccines present a novel platform with advantages like stability and sustained antigen expression.
Purpose of the Study:
- To review recent advances in circular RNA (circRNA) vaccine development.
- To highlight the potential of circRNA vaccines against diverse pathogens, including antibiotic-resistant bacteria.
- To discuss challenges and future directions for circRNA vaccine technology.
Main Methods:
- Review of recent scientific literature on circRNA vaccine development.
- Analysis of synthetic circularization techniques and delivery approaches.
- Examination of immunological mechanisms induced by circRNA vaccines.
Main Results:
- circRNA vaccines demonstrate high stability, low innate immunogenicity, and sustained antigen expression.
- circRNA vaccines can induce protective immune responses against viral and bacterial pathogens.
- Evidence supports the application of circRNA vaccines against antibiotic-resistant bacteria.
Conclusions:
- circRNA vaccines are a versatile and emerging platform for next-generation vaccine innovation.
- This technology offers a viable alternative to conventional antimicrobial strategies.
- Further research is needed to address current challenges and optimize circRNA vaccine development.
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Vaccinations
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
The Antiviral System of Bacteria and Archaea: CRISPR
Humoral Immune Responses

